Sign in to confirm you’re not a bot
This helps protect our community. Learn more

Resverlogix Laboratory/Office Video Footage

ResverlogixRVX
109 subscribers
159 views 5 years ago
https://www.resverlogix.com/ Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. We provide novel science, clinical and value-based health solutions to key stakeholders such as pharmaceutical, physician, and health payer groups. Resverlogix is a pioneer in the landscape of epigenetics. Today, apabetalone – discovered in 2006 – is the world leader in a new class of drugs designed to regulate gene expression through the inhibition of bromodomain and extraterminal domain (BET) proteins. Through this mechanism, we believe we can improve the lives of our patients by restoring biological functions – altered by serious illnesses such as cardiovascular disease – to a healthy state. The prevalence of BET proteins in the human body allows apabetalone to simultaneously target multiple disease-causing biological processes – leading a new paradigm shift in the treatment of chronic disease. ...more
...more
Comments are turned off. Learn more
Resverlogix Laboratory/Office Video Footage
N/ALikes
159Views
2019Sep 19
https://www.resverlogix.com/ Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. We provide novel science, clinical and value-based health solutions to key stakeholders such as pharmaceutical, physician, and health payer groups. Resverlogix is a pioneer in the landscape of epigenetics. Today, apabetalone – discovered in 2006 – is the world leader in a new class of drugs designed to regulate gene expression through the inhibition of bromodomain and extraterminal domain (BET) proteins. Through this mechanism, we believe we can improve the lives of our patients by restoring biological functions – altered by serious illnesses such as cardiovascular disease – to a healthy state. The prevalence of BET proteins in the human body allows apabetalone to simultaneously target multiple disease-causing biological processes – leading a new paradigm shift in the treatment of chronic disease.

ResverlogixRVX

109 subscribers